ALYSON DAVIS-EUDY: Open Payments
NPI 1356117394 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 45 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $392 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 26 | $296 |
| ABBVIE INC. | 9 | $213 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| UCB, Inc. | 2 | $41 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $18 |
| ARGENX US, INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Arteriocyte Medical Systems, Inc. | 1 | $16 |
Products named: Infinion 16, QULIPTA, VYALEV, UBRELVY, Artisan, General - Therapies, INGREZZA, Briviact.
Industry payments across AL — which companies pay providers there.
